Information Provided By: 
Fly News Breaks for July 15, 2019
NDRA
Jul 15, 2019 | 07:06 EDT
H.C. Wainwright analyst Vernon Bernardino started Endra Life Sciences with a Buy rating and $6 price target. The analyst sees broad potential of the company's TAEUS platform to expand the utility of conventional ultrasound imaging. He recommends buying the shares ahead of the potential to gain CE Mark for TAEUS in the second half of 2019.
News For NDRA From the Last 2 Days
There are no results for your query NDRA
